Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 10.64 | N/A |
| PEG Ratio (TTM) | 2.23 | N/A |
| P/S Ratio (TTM) | 1.23 | N/A |
| P/B Ratio (TTM) | 1.89 | N/A |
| P/FCF Ratio (TTM) | 5.88 | N/A |
| Price to 5YR AVG Earnings Ratio | 17.66 | N/A |
| Price to 5YR AVG FCF Ratio | 8.43 | N/A |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.73% | N/A |
| ROE (TTM) | 19.09% | N/A |
| Net Profit Margin (TTM) | 11.64% | N/A |
| ROIC 5YR AVG | 13.06% | N/A |
Growth (60%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 5.27% | 12.55% | 13.29% |
| Revenue | 2.15% | 5.82% | 5.41% |
| Net Income | 4.51% | 11.73% | 9.91% |
| Cash Flow | 1.83% | 13.14% | 8.52% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 16.86 | N/A |
| Quick Ratio (TTM) | 16.86 | N/A |
| D/E Ratio (TTM) | 0.26 | N/A |
| Interest Coverage (TTM) | 19.90 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 1.28 | N/A |
| LTL to 5YR AVG FCF | 1.15 | N/A |
| Shares Outstanding Growth 5YR AVG | -3.00% | N/A |